|Traded as||BM&F Bovespa: HYPE3
|Headquarters||São Paulo, Brazil|
|Key people||Claudio Bergamo,(CEO)|
|Revenue||US$ 2.0 billion (2012)|
|Net income||US$ 99.5 million (2012)|
Currently, Hypermarcas operates five industrial complexes with 13 different production lines, located in the states of Goias, Santa Catarina, São Paulo and Rio Grande do Sul has a portfolio of brands and products with established demand that the Company has historically provided a solid stream cash. The Company has a directors and shareholders with experience and know-how in the goods of mass consumption. Hypermarcas has extensive experience in identifying, attracting, acquiring and integrating businesses in this sector, the implementation of policies for growth and investment in marketing. These factors make possible the growth of their brands.
Among the products marketed by Hypermarcas, there is a topical solution of chlorhexidine digluconate, used to clean and disinfect small wounds, that is sold under the brand name of "Merthiolate". This is distinguished from thiomersal, which is the traditional organomercury compound sold under the brand name of "Merthiolate".